A composition of matter patent protects a new substance itself: a chemical compound, a physical mixture, an alloy, or a biological material. It is one of four categories of invention eligible for patent protection under federal law,1United States Patent and Trademark Office. MPEP 2106.03 – Eligibility Step 1: The Four Categories of Statutory Subject Matter and unlike patents on machines or methods, it protects what a substance is rather than what it does or how it is made. The term runs 20 years from the filing date of the earliest non-provisional application to which the patent claims priority.2Office of the Law Revision Counsel. 35 USC 154 – Contents and Term of Patent; Provisional Rights
What Counts as a Composition of Matter
The patent statute lists “composition of matter” alongside processes, machines, and manufactures as eligible subject matter but does not define the phrase further.3Office of the Law Revision Counsel. 35 USC 101 – Inventions Patentable The Supreme Court filled that gap in Diamond v. Chakrabarty, reading the term broadly to include all compositions of two or more substances and all composite articles, whether produced by chemical reaction, mechanical blending, or any other means, and regardless of whether the result is a gas, liquid, powder, or solid.4Justia. Diamond v Chakrabarty, 447 US 303 (1980)
In practical terms, the category covers synthetic polymers, pharmaceutical formulations, metal alloys, genetically engineered organisms, novel chemical compounds, and composite materials. What distinguishes a composition claim from other patent claims is that it describes the substance’s identity: its chemical structure, its ingredients, or its physical arrangement. A single invention can sometimes support more than one type of claim. A new drug, for instance, may support both a composition claim and a method-of-treatment claim, but each claim has to meet the patentability standards on its own.
There are limits. The substance has to have a physical existence, so abstract ideas, mathematical formulas, and laws of nature are out. Naturally occurring materials in their natural state are also outside the category. Unaltered DNA sequences and minerals as found in the earth are not patentable compositions, a line the Supreme Court reinforced in Association for Molecular Pathology v. Myriad Genetics.5Legal Information Institute. Association for Molecular Pathology v Myriad Genetics, Inc To move from discovery to invention, human intervention has to change the material in a meaningful way, whether by isolating a compound in a form that does not exist naturally, creating a new molecular structure, or combining known ingredients into something with genuinely different properties.
The Three Tests the Substance Has to Pass
Fitting the category is only the first step. The composition also has to satisfy three statutory requirements.
Novelty. The composition cannot have been previously patented, described in a publication, publicly used, or offered for sale before the filing date. Even the inventor’s own public disclosure can create a bar if the application is not filed within one year of that disclosure.6Office of the Law Revision Counsel. 35 USC 102 – Conditions for Patentability; Novelty
Non-obviousness. The invention has to be more than a predictable tweak. If someone with ordinary skill in the relevant field would have found the composition obvious given what already existed, the application will be denied. Many composition claims fail here, with the examiner concluding that combining known ingredients in a new ratio would have been an expected variation.7Office of the Law Revision Counsel. 35 USC 103 – Conditions for Patentability; Non-obvious Subject Matter
Utility. The substance must provide a specific, substantial, and credible benefit. A compound that exists only in theory, or whose only claimed use is speculative, will not qualify.3Office of the Law Revision Counsel. 35 USC 101 – Inventions Patentable
Applicants who file related applications on variations of the same composition also run into a doctrine called double patenting. If the claims in a later application are not meaningfully distinct from claims already granted in an earlier patent, the USPTO will reject them to prevent an unjustified extension of exclusivity. A terminal disclaimer, committing both patents to expire on the same date and stay under common ownership, will usually overcome that rejection.
What the Application Has to Contain
A composition of matter application calls for unusually detailed technical documentation, because the examiner needs enough information to confirm the substance actually exists and works as described.
The specification, which is the main body of the application, must describe the invention clearly enough that someone skilled in the field could reproduce it.8Office of the Law Revision Counsel. 35 USC 112 – Specification For compositions, that usually means chemical formulas, molecular structures, synthesis methods, and experimental data demonstrating the substance’s properties. The specification also has to disclose the best version of the invention the applicant knows about. You cannot hold back a superior formulation while patenting an inferior one.
The claims section defines the legal boundaries of what is protected. Drafting claims for compositions is a balancing act. Too narrow, and competitors design around them easily. Too broad, and the examiner rejects them as covering prior art. Claims often specify ranges of ingredients and proportions rather than a single exact recipe, which gives the patent wider coverage while still requiring that each combination within the range actually work.
When the composition involves biological material that cannot be fully described in writing, such as a specific microbial strain, the applicant may need to deposit a physical sample with a recognized biological depository.9eCFR. 37 CFR Part 1 Subpart G – Deposit of Biological Material The deposit can be made before or during pendency, but if the application is otherwise ready for approval and no deposit has been made, the USPTO will set a non-extendable three-month deadline to complete it.
Every application must also include an Information Disclosure Statement listing all prior art the applicant knows about.10United States Patent and Trademark Office. Forms for Patent Applications Patent applicants owe a duty of candor, and deliberately withholding known prior art can render an issued patent unenforceable.
Filing Options and Fees
Applications are submitted through Patent Center, the USPTO’s electronic filing portal.11United States Patent and Trademark Office. Apply for Patent Paper filing is available for applicants who cannot use the electronic system, but it carries a surcharge.
Inventors who are not yet ready to file a full application can start with a provisional patent application, which establishes an early filing date at a fraction of the cost. The filing fee for a provisional is $325 for a large entity, $130 for a small entity, or $65 for a micro entity.12United States Patent and Trademark Office. USPTO Fee Schedule A provisional does not require formal claims or a declaration of inventorship, so it is faster and cheaper to prepare. The tradeoff is a hard deadline: the applicant must file a complete non-provisional utility application claiming priority to the provisional within 12 months, or the provisional is automatically abandoned. Used strategically, a provisional effectively adds a year to the patent’s commercial life, because the 20-year term runs from the non-provisional filing date rather than the earlier provisional date.
A non-provisional utility application requires three separate fees at filing: a basic filing fee, a search fee, and an examination fee. Combined, these total $2,000 for a large entity, $800 for a small entity, or $400 for a micro entity.12United States Patent and Trademark Office. USPTO Fee Schedule Small entities are businesses with fewer than 500 employees. Micro entities have to meet additional requirements, including limited prior filings and income below a specified threshold. Fees have to be paid at the time of submission; failing to pay can result in the application being treated as abandoned.
Government fees are only part of the cost. Attorney fees for drafting and prosecuting a composition of matter patent vary widely with the complexity of the chemistry and the attorney’s location, and biotech and pharmaceutical compositions tend to run higher because of the specialized knowledge required.
What to Expect During Examination
After filing, expect a long wait. The USPTO currently averages about 22 months before mailing the first office action on a utility application,13United States Patent and Trademark Office. Patents Dashboard – Pendency and composition applications in complex technology areas like biotechnology can take longer.
The first office action is where the examiner’s analysis lands. It frequently includes rejections, which is normal rather than fatal. The examiner might reject claims as obvious over prior art, challenge the utility of the composition, or argue that the specification does not adequately describe or enable the invention. The standard response deadline is three months from the mailing date of the office action, and applicants can purchase extensions one month at a time up to a maximum of six months total.14United States Patent and Trademark Office. MPEP 710 – Period for Reply Letting the six-month deadline pass without responding abandons the application.
Responding to an office action usually involves amending the claims, presenting arguments against the examiner’s rejections, or submitting additional data. For composition patents, applicants often need to provide comparative test results showing that the substance has unexpected properties that distinguish it from the prior art. This back-and-forth can go through several rounds.
When the examiner is satisfied, the USPTO issues a Notice of Allowance.15United States Patent and Trademark Office. MPEP 1303 – Notice of Allowance The applicant then has three months, with no extensions available, to pay the issue fee: $1,290 for a large entity, $516 for a small entity, or $258 for a micro entity.12United States Patent and Trademark Office. USPTO Fee Schedule Missing this deadline abandons an application that already represents years of prosecution and substantial money.
What the Patent Protects Once Granted
An issued composition of matter patent gives the owner the right to exclude others from making, using, selling, offering to sell, or importing the patented substance anywhere in the United States.2Office of the Law Revision Counsel. 35 USC 154 – Contents and Term of Patent; Provisional Rights Protection is limited to U.S. territory; separate filings are needed for other countries.
Composition claims are among the strongest in patent law because they cover the substance itself, regardless of how it is made or what it is used for. A patent on a new chemical compound blocks competitors from manufacturing that compound by any method, not just the specific synthesis described in the patent.
Enforcement happens in federal court. A patent holder who discovers infringement can seek an injunction to stop the unauthorized activity along with damages, whether measured as lost profits or a reasonable royalty. The patent holder carries the burden of proving infringement, which for a composition claim means showing that the accused product has the same chemical identity or falls within the claimed ranges of ingredients.
Keeping the Patent Alive
A patent does not stay in force automatically for 20 years. The owner has to pay maintenance fees at three intervals after issuance, and the amounts escalate sharply:12United States Patent and Trademark Office. USPTO Fee Schedule
- 3.5 years after issuance: $2,150 (large entity), $860 (small), $430 (micro)
- 7.5 years after issuance: $4,040 (large entity), $1,616 (small), $808 (micro)
- 11.5 years after issuance: $8,280 (large entity), $3,312 (small), $1,656 (micro)
Missing a payment does not immediately kill the patent. A six-month grace period follows each due date, during which the fee can still be paid with a $540 surcharge ($216 for small entities, $108 for micro entities).16eCFR. 37 CFR 1.362 – Time for Payment of Maintenance Fees If the grace period expires without payment, the patent lapses on the anniversary of its grant date in the 4th, 8th, or 12th year.
Extra Time for USPTO Delays
When the USPTO takes longer than it should to process an application, the patent term is extended day for day to compensate.17United States Patent and Trademark Office. MPEP 2731 – Period of Adjustment The calculation tracks several kinds of delay, including the office failing to issue a first action within 14 months of filing, failing to respond to applicant submissions within four months, and failing to issue the patent within three years of filing. Delays caused by the applicant are subtracted from the total. With first-action pendency averaging more than 22 months, many composition patents receive at least some adjustment.
Extra Time for Regulatory Review
Drugs, medical devices, and certain other regulated products often cannot be sold for years after the patent issues because they are waiting for FDA approval. To compensate, the patent owner can apply for a term extension of up to five years to recover time lost to regulatory review.18Office of the Law Revision Counsel. 35 US Code 156 – Extension of Patent Term The application has to be filed within 60 days of receiving regulatory approval, it must be the first approval for that product, and only one patent per product can be extended.